Codeine Linctus Reclassified as Prescription-Only by UK MHRA

Medicines and Healthcare Products UK has updated codeine linctus, an oral solution or syrup licensed for treating dry cough in adults, as a prescription-only treatment due to abuse, dependence and dose magnitude. Will be done

Codeine linctus is an opioid medication that was previously available over the counter under the supervision of a pharmacist but is now available by prescription after review by a medical professional.Since 2019, there have been increasing reports in the media about the misuse of linctus codeine as an ingredient in a recreational drink called "Purple Drink."

The decision to reorganize the medicine was made after consulting specialists, healthcare professionals and patients. Nine hundred ninety-two responses were received.

The MHRA launched an inquiry after a yellow card revealed cases of abuse of the drug, and it should not be used as a cough suppressant. Responses to the consultation confirmed that pharmacists are under pressure to prescribe drugs to people who have an addiction.

Dr Alison Cave, head of safety at the MHRA, said: "Patient safety is our top priority. Codeine linctus is an effective long-term cough medicine, but because it is an opioid,"Thank you to all patients. , specialists and health professionals who participated in our discussions.

“Therefore, based on the reports of abuse we have received, we have reclassified Codeine Lintose as a prescription-only medicine for the benefit of patients, carers and healthcare professionals across the UK.